Medivation Pharma

Xtandi Is Being Distributed Through a Network of Specialty Pharmacies and Distributors
Nov 30, 2012
Medivation and Astellas Pharma have launched Xtandi (enzalutamide) capsules for patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. Xtandi, an oral, once-daily androgen receptor inhibitor ...

Tags: Medivation Pharma, Astellas Pharma, Xtandi capsules